We are live on ! Find out more
CH

CVS Health Portfolio holdings

AUM $225M
1-Year Est. Return 8.77%
This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+8.77%
3 Year Est. Return
+48.72%
5 Year Est. Return
10 Year Est. Return
AUM
$187M
AUM Growth
-$6.34M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
9
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 0.17%
2 Financials 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$812B
$96M 51.34%
224,596
HDV
2
iShares Core High Dividend ETF
HDV
$15.3B
$30.3M 16.22%
1,533,955
VYM icon
3
Vanguard High Dividend Yield ETF
VYM
$83.4B
$26M 13.92%
252,032
XLP icon
4
State Street Consumer Staples Select Sector SPDR ETF
XLP
$15B
$19.4M 10.35%
281,400
XLE icon
5
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
$13.3M 7.12%
294,600
LMDXW
6
DELISTED
LumiraDx Limited Warrant
LMDXW
$1.27M 0.68%
5,352,106
HCAT icon
7
Health Catalyst
HCAT
$127M
$327K 0.17%
32,273
PRU icon
8
Prudential Financial
PRU
$42.2B
$255K 0.14%
2,683
LQD icon
9
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33.3B
$94.9K 0.05%
930

Similar funds

CVS Health's Q3 2023 Portfolio in Review

As of Q3 2023, CVS Health held 9 positions worth $187M, down 3.3% from $193M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 0%. CVS Health opened no new positions and made no exits, leaving the 9-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 0.17% of assets, down from 0.21% a quarter earlier, followed by Financials.

  • CVS Health's ten largest holdings make up 100% of its $187M portfolio in Q3 2023.
  • CVS Health opened 0 new positions and closed 0 in Q3 2023.
  • CVS Health's portfolio value fell 3.3% quarter-over-quarter to $187M.

Based on CVS Health's 13F filing for Q3 2023, filed 3 Nov 2023.